Meili P. Sun

No. 105 Jiefang Road
Jinan, 250013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Tumor-targeting semi-rigid metal-organic-polymer framework nanoparticles with high adaptability and bioavailability.

Tumor-targeting semi-rigid metal-organic-polymer framework nanoparticles with high adaptability and bioavailability.

Journal: Journal of materials chemistry. B

Published: June 23, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

Anti-VGCC negative and Anti-SOX1 positive Lambert-Eaton myasthenic syndrome as the initial presentation of small cell lung cancer: a case report.

Anti-VGCC negative and Anti-SOX1 positive Lambert-Eaton myasthenic syndrome as the initial presentation of small cell lung cancer: a case report.

Journal: Frontiers in oncology

Published: March 08, 2026

SFRT alleviates symptoms associated with bulky advanced cancer: a retrospective single-center cohort analysis.

SFRT alleviates symptoms associated with bulky advanced cancer: a retrospective single-center cohort analysis.

Journal: Frontiers in oncology

Published: February 25, 2026

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Journal: Nature medicine

Published: January 29, 2026

A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours.

A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours.

Journal: EBioMedicine

Published: January 13, 2026

Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation".

Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation".

Journal: Clinical and molecular hepatology

Published: December 02, 2025

A scientometric study on the characteristics of herbal medicine and identification of herbaceous agents for treatment of periodontal diseases.

A scientometric study on the characteristics of herbal medicine and identification of herbaceous agents for treatment of periodontal diseases.

Journal: Journal of dental sciences

Published: November 30, 2025

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.

Journal: Cancer communications (London, England)

Published: November 29, 2025

Plasma proteomic architecture of educational attainment associated with morbidity and mortality.

Plasma proteomic architecture of educational attainment associated with morbidity and mortality.

Journal: Journal of advanced research

Published: September 26, 2025

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 09, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026